Translation
Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail.
Summary of Non-Consolidated Financial Results
for the Year Ended April 30, 2022
(Based on Japanese GAAP)
June 10, 2022 | |||||||||||||||||||||||||||
Company name: | HEROZ, Inc. | ||||||||||||||||||||||||||
Stock exchange listing: | Tokyo | ||||||||||||||||||||||||||
Stock code: | 4382 | URL | https://www.heroz.co.jp | ||||||||||||||||||||||||
Representative: | Representative Director and Co-CEO | Takahiro Hayashi | |||||||||||||||||||||||||
Inquiries: | Executive Officer and CFO | Hiroya Mori | TEL 03(6435)2495 | ||||||||||||||||||||||||
Scheduled date of ordinary general meeting of shareholders: | July 28, 2022 | ||||||||||||||||||||||||||
Scheduled date to file Securities Report: | July 29, 2022 | ||||||||||||||||||||||||||
Scheduled date to commence dividend payments: | - | ||||||||||||||||||||||||||
Preparation of supplementary material on financial results: | Yes | ||||||||||||||||||||||||||
Holding of financial results meeting: | Yes | (for institutional investors and analysts) | |||||||||||||||||||||||||
(Amounts less than one million yen are rounded down) | |||||||||||||||||||||||||||
1. Non-consolidated financial results for the year ended April 30, 2022 (from May 1, 2021 to April 30, 2022) | |||||||||||||||||||||||||||
(1) Non-consolidated operating results | Percentages indicate year-on-year changes | ||||||||||||||||||||||||||
Net sales | EBITDA | Operating profit | Ordinary profit | Profit | |||||||||||||||||||||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | ||||||||||||||||||
Year ended April 30, 2022 | 1,482 | - | 188 | - | 34 | - | 87 | - | 49 | - | |||||||||||||||||
Year ended April 30, 2021 | 1,556 | 0.8 | 366 | (30.0) | 294 | (35.9) | 285 | (29.4) | 207 | (18.9) | |||||||||||||||||
※EBITDA = Operating Profit + Depreciation + Amortization | |||||||||||||||||||||||||||
Earnings per share | Diluted earnings per | Profit/equity | Ordinary profit/total | Operating profit/net | |||||||||||||||||||||||
share | assets | sales | |||||||||||||||||||||||||
Yen | Yen | % | % | % | |||||||||||||||||||||||
Year ended April 30, 2022 | 3.29 | 3.26 | 0.8 | 1.3 | 2.3 | ||||||||||||||||||||||
Year ended April 30, 2021 | 13.85 | 13.67 | 3.3 | 4.4 | 18.9 | ||||||||||||||||||||||
(2) Non-consolidated financial position | |||||||||||||||||||||||||||
Total assets | Net assets | Equity ratio | Net assets per share | ||||||||||||||||||||||||
Millions of yen | Millions of yen | % | Yen | ||||||||||||||||||||||||
As of April 30, 2022 | 6,635 | 6,440 | 97.1 | 428.65 | |||||||||||||||||||||||
As of April 30, 2021 | 6,546 | 6,403 | 97.8 | 426.13 | |||||||||||||||||||||||
(3) Non-consolidated cash flows | |||||||||||||||||||||||||||
Cash flows from | Cash flows from | Cash flows from | Cash and cash equivalents | ||||||||||||||||||||||||
operating activities | investing activities | financing activities | at end of period | ||||||||||||||||||||||||
Millions of yen | Millions of yen | Millions of yen | Millions of yen | ||||||||||||||||||||||||
Year ended April 30, 2022 | 198 | (2,092) | 0 | 3,660 | |||||||||||||||||||||||
Year ended April 30, 2021 | 360 | (384) | 15 | 5,554 | |||||||||||||||||||||||
2. Cash dividends | |||||||||||||||||||||||||||
Annual dividends per share | Total cash | Dividend payout | Ratio of dividends | ||||||||||||||||||||||||
ratio (Non- | to net assets (Non- | ||||||||||||||||||||||||||
1st quarter-end | 2nd quarter-end | 3rd quarter-end | Fiscal year-end | Total | dividends (Total) | consolidated) | consolidated) | ||||||||||||||||||||
Yen | Yen | Yen | Yen | Yen | Millions of yen | % | % | ||||||||||||||||||||
Year ended April 30, 2021 | - | 0.00 | - | 0.00 | 0.00 | - | - | - | |||||||||||||||||||
Year ended April 30, 2022 | - | 0.00 | - | 0.00 | 0.00 | - | - | - | |||||||||||||||||||
Year ending April 30, 2023 | - | 0.00 | - | 0.00 | 0.00 | - | |||||||||||||||||||||
(Forecast) | |||||||||||||||||||||||||||
1
3. Forecast of non-consolidated financial results for the year ending April 30, 2023 (from May 1, 2022 to April 30, 2023)
Percentages indicate year-on-year changes
Net sales | Operating profit | Ordinary profit | Profit | Earnings per share | |||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | Yen | |
Full year | 1,700 | 14.6 | 50 | 43.7 | 100 | 13.9 | 60 | 21.4 | 3.99 |
4. Notes
(1) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements
Changes in accounting policies due to revisions to accounting standards and other regulations: | Yes |
Changes in accounting policies due to other reasons: | No |
Changes in accounting estimates: | No |
Restatement of prior period financial statements: | No |
(2) Number of issued shares (common shares)
Total number of issued shares at the end of the period (including treasury shares)
As of April 30, 2022 | 15,025,582 | shares | As of April 30, 2021 | 15,025,582 | shares | |
Number of treasury shares at the end of the period | ||||||
As of April 30, 2022 | - shares | As of April 30, 2021 | - shares | |||
Average number of shares during the period | ||||||
Year ended April 30, 2022 | 15,025,582 | shares | Year ended April 30, 2021 | 14,952,715 | shares |
2
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
HEROZ Inc. published this content on 13 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 June 2022 07:42:20 UTC.